Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study
Claus G. Roehrborn1, Jack Barkin2, Steven N. Gange3, Neal D. Shore4, Jonathan L. Giddens5, Damien M. Bolton6, Barrett E. Cowan7, Anthony L. Cantwell8, Kevin T. McVary9, Alexis E. Te10, Shahram S. Gholami11, William G. Moseley12, Peter T. Chin13, William T. Dowling14, Sheldon J. Freedman15, Peter F. Incze16, K. Scott Coffeld17, Sean Herron18, Prem Rashid19, Daniel B. Rukstalis20
Canadian Journal of Urology, Vol.24, No.3, pp. 8802-8813, 2017
Abstract Introduction: To report the five year results of a prospective, multi-center, randomized, blinded sham control trial of the Prostatic Urethral Lift (PUL) in men with bothersome lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Materials and methods: At 19 centers in North America and Australia, 206 subjects ≥50 years old with International Prostate Symptom Score (IPSS) >12, peak flow rate (Qmax) ≤12 mL/s, and prostate volume 30cc-80cc were randomized 2:1 to the PUL procedure or blinded sham control. In PUL permanent UroLift implants are placed to hold open the lateral lobes of the prostate… More >